Drug shortage
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection · Vantive US Healthcare LLC
FDA drug shortage · To Be Discontinued · updated Aug 3, 2026
Key facts
| Generic name | Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution |
|---|---|
| Company | Vantive US Healthcare LLC |
| Presentation | DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0433-51) |
| Dosage form | Solution |
| Status | To Be Discontinued |
| Therapeutic category | Renal |
| Package NDCs | 0941-0433-51 |
| First posted | Aug 3, 2026 |
| Last updated | Aug 3, 2026 |
| Discontinued | Aug 3, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: